Abstract. The distribution of the extracellular matrix glycoprotein, tenascin, in normal skin and healing skin wounds in rats, has been investigated by immunohistochemistry. In normal skin, tenascin was sparsely distributed, predominantly in association with basement membranes. In wounds, there was a marked increase in the expression of tenascin at the wound edge in all levels of the skin. There was also particularly strong tenascin staining at the dermal-epidermal junction beneath migrating, proliferating epidermis. Tenascin was present throughout the matrix of the granulation tissue, which filled full-thickness wounds, but was not detectable in the scar after wound contraction was complete. The distribution of tenascin was spatially and temporally different from that of fibronectin, and tenascin appeared before laminin beneath migrating epidermis. Tenascin was not entirely codistributed with myofibroblasts, the contractile wound fibroblasts. In EM studies of wounds, tenascin was localized in the basal lamina at the dermalepidermal junction, as well as in the extracellular matrix of the adjacent dermal stroma, where it was either distributed homogeneously or bound to the surface of collagen fbers. In cultured skin explants, in which epidermis migrated over the cut edge of the dermis, tenascin, but not fibronectin, appeared in the dermis underlying the migrating epithelium. This demonstrates that migrating, proliferating epidermis induces the production of tenascin. The results presented here suggest that tenascin is important in wound healing and is subject to quite different regulatory mechanisms than is fibronectin.
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W
'OUND healing is a complex series of biological events that in many ways resembles the process of development. Cellular proliferation, migration, and differentiation, as well as tissue remodeling, are all events that occur during embryonic and postnatal development and recur during wound healing. Many of the molecular mechanisms responsible for these events are apparently common to development and wound healing. Some growth factors that are known or thought to promote wound healing also have roles in development, for example, the fibroblast growth factors (reviewed by Thomas, 1987) and transforming growth factor-13 (Mustoe et al., 1987; Seyedin et al., 1986) . Some extracellular matrix molecules (e.g., fibronectin and collagen type III) that are abundant in embryonic skin and less abundant in adult skin, are reexpressed at high levels in healing skin wounds (Kurkinen et al., 1980 ; review by AIvarez, 1986) .
Extracellular matrix proteins are known to be important in many phases of wound healing. Fibronectin is present in the clot that forms at the earliest stage of healing and is abundant in the granulation tissue that fills a deep skin wound (Grinnell et al., 1981) . Fibronectin is thought to aid in phagocytosis of wound debris and promotes migration of wound fibroblasts, endothelial cells, and probably epithelial cells Dr. E. J. Mackie's present address is Sandoz AG, Preclinical Research 360/405, Switzerland. over the wound (reviewed by Murphy-Ullrich and Mosher, 1986) . Collagen type III is increased in the early granulation tissue and is later replaced by collagen type I. These two collagen types impart strength to the healing wound (reviewed by Cohen and McCoy, 1983) . Collagen and fibronectin are also chemotactic for fibroblasts (reviewed by Alvarez, 1986) .
Tenascin, also known as myotendinous antigen, glioma mesenchymal extracellular matrix antigen, hexabrachion, brachionectin, J1, and cytotactin, is an extracellular matrix glycoprotein with a strikingly limited distribution in the mesenchymal components of various organs in vertebrate embryos (Chiquet and Fambrough, 1984a; Chiquet-Ehrismann et al., 1986; Bourdon et al., 1983; Vaughan et al., 1987; Erickson et al., 1987; Faissner et al., 1988; Hoffman et al., 1988) . Its tissue distribution suggests that tenascin is important in the development of mammary gland, hair follicle (Chiquet-Ehrismann et al., 1986 , Inaguma et al., 1988 , muscle (Chiquet and Fambrough, 1984a) , tooth (Thesleff et al., 1987) , cartilage and bone (Mackie et al., 1987b) , kidney (Aufderheide et al., 1987) , and neural crest and its derivatives Epperlein et al., 1988) , as well as the central nervous system (Kruse et al., 1985) . Tenascin is absent or expressed at low levels in the adult mammary gland, but is abundant in mammary carcinomas (Mackie et al., 1987a , Inaguma et al., 1988 .
Little is known about the function of tenascin. Tenascin as a substratum supports the growth of primary mammary tumor cells in serum-free culture (Chiquet-Ehrismann et al., 1986 ) and promotes cartilage differentiation in vitro (Mackie et al., 1987b) . Tenascin in the culture medium partially inhibits the attachment of wing-bud cells to fibronectin (Mackie et al., 1987b) . In contrast, tenascin appears to act as a cell adhesion molecule in the central nervous system (Kruse et al., 1985) .
This study was undertaken to investigate the distribution of tenascin in normal skin and healing skin wounds. The study revealed that tenascin is sparsely distributed in normal rat skin, but strongly expressed in healing wounds. The in vivo distribution studies, as well as in vitro studies, demonstrate that mechanisms regulating expression of tenascin are quite distinct from those for fibronectin.
Materials and Methods

Antisera
Tenascin was purified from the conditioned medium of primary rat embryo fibroblast cultures grown in DME containing 10% FCS. The purification was carded out according to the method described by Chiquet and Fambrough (1984b) , but instead of an mAb column, a column containing polyclonal antiserum to chicken tenascin was used. Briefly, after ammonium sulphate precipitation and removal of fibronectin by gelatin-agarose (Sigma Chemical Co., St. Louis, MO), the extract was loaded onto a column containing rabbit antiserum to chicken tenascin (Chiquet-Ehrismann et al., 1986) coupled to cyanogen bromide-activated Sopharose-4B (Sigma Chemical Co.). The column was then washed with PBS and rat tenascin was eluted with 50 mM ethanolamine (pHI 1.5) and then dialyzed against PBS. Antiserum to rat tenascin ("¢50 Ltg/injection) was produced in rabbits and processed as described for chicken tenascin (Chiquet-Ehrismarm et al., 1986) . The specificity of the antiserum was confirmed by Western blot analysis. The antiserum detected only two bands, of *240 and 200 kD, in conditinned medium of rat embryo fibroblasts. This is in agreement with the subunit molecular weights previously described for rat tenascin (ChiquetEhrismann et al., 1986) . The antiserum did not react with FCS or plasma flbronectin (Boehringer Mannheim, FRGL Antiserum to mouse laminin was prepared in a guinea pig using the same procedure as for tenascin and 100 I.tg laminin (Bethesda Research Laboratories, Gaithersburg, MD) per injection. Rabbit antiserum to human plasma fibronectin was purchased from Gibco Laboratories (Basel, Switzerland).
Animals
3-mo-old male or female outbred Sprague-Dawley rats were anesthetized. The abdomen was shaved or depilated with a commercial depilatory cream and then three scalpel incisions, one deep, one medium, and one superficial, were made in the abdominal skin. Deep skin wounds were full-thickness wounds in which all layers were cut. Medium-thickness wounds cut through all layers except the cutaneous muscle and varying amounts of the adipose tissue layer. Superficial wounds were only cut through the epidermis and part of the dermis. Wounds were left uncovered and all healed without complications. Two animals were killed at each of the following time points: 15 and 24 h and 2, 3, 6, 10, 14, and 22 d. The wounds with some surrounding skin were excised and processed for histology. Four rats whose wounds were to be used for electron microscopy were also anesthetized 6 d after being wounded and then subjected to intracardiac perfusion with 4% paraformaldehyde and 0.1% glutaraldehyde in calcium-and magnesium-free Hanks' solution (CMF) I before the wounds were excised.
Histology
Tissues for immunohistochemistry at the light microscope level were fixed in 4% paraformaldehyde in potassium phosphate buffer (pH 7.4) for 4 h, washed in PBS, and then placed in 30% sucrose in PBS overnight. The wounds were then embedded in OCT compound (Tissue Tek; Miles Laboratories Inc., Naperville, IL), frozen rapidly on ethanol/dry ice, and stored at -70°C. Cryostat sections (10-20 ~tm) were cut and placed on gelatin-1. Abbreviation used in this paper: CMF, calcium-and magnesium-free Hank's solution. coated slides. Sections containing adipose tissue were placed in ether for 5 min to remove fat before staining. Sections to be stained by the immunoperoxidase method were then immersed in 0.3 % hydrogen peroxide in 40 % methanol to remove endogenous peroxidase staining. Some sections were treated with bovine testicular hyaluronidase (0.1 mg/ml at 22"C for 30 min; Calbiochem-Behring Corp., Lucerne, Switzerland) or type I collngenase (0.5 mg/ml) at 37°C for 20 rain; Sigma Chemical Co.) before staining. Indirect immunofluorescence was carried out as described . Some sections stained with anti-tenascin or preimmune serum, followed by FITC anti-rabbit Ig, were counterstained with TRITC-phalloidin (0.5 mg/ml in PBS for 2 min; Sigma Chemical Co.) and then washed in PBS before the coverslip was applied, lmmunoperoxidase staining was carded out according to the same procedure but with peroxidase-labeled swine anti-rabbit or goat anti-guinea pig Ig (Dakopatts, Glostrup, Denmark) as the second antibody. Chloronaphthol was used as a chromogenic substrate.
Some sections were stained with hematoxylin and eosin by standard methods.
Electron Microscopy
The excised wounds were fixed for 2 h in the same solution used for perfusion (described above), washed several times in CMF and cryoprotected by immersion in 20% sucrose in CMF for 4 h. 60-gm free-floating sections were cut with a freezing microtome. Suppression of endogenous peroxidase activity was carried out as described above. After being rinsed several times, the sections were incubated with anti-tenascin or preimmune serum (l:100 in CMF containing 1 rng BSA/ml) for 2 h, washed (four times for 5 min each) in CMF, and then incubated in peroxidase-labeled goat antirabbit Ig for 2 h. The sections were washed for l h with several changes of buffer, and the peroxidase activity was developed with pyrocatechol/ p-phenylenediamine (l mg/ml in 0.15 M ammonium acetate buffer containing 0.01% hydrogen peroxide). The stained sections were washed, posttixed in 1% osmium tetroxide in cacodylate buffer, and embedded in EPON. The sections were resectioned and examined without counterstaining in a Phillips electron microscope at 80 kV. Some wounds were fixed in 4% paraformaldehyde, 2.5 % glutaraldebyde/CMF and processed for conventional EM histology.
Cell and tissue Culture
Skin explants were cultured according to the method of Hashimoto and Marks (1984) . Rats, as used for the wound experiments, were killed and the abdomens were depilated. Sheets of skin ~0.5 mm thick, were removed with a scalpel and cut into pieces '~3 × 2 mm. The explants were floated, epidermis upward, in DME with or without FCS. The explants were cultured for 1-7 d and then fixed and processed for histology as for the wound tissues.
Results
In this study, the distribution of tenascin in skin wounds of various thicknesses was compared with that of fibronectin. The results obtained for fibronectin in normal skin and healing wounds were in agreement with those previously obtained by GrinneU et al. (1981) . The distribution of laminin was used to indicate the status of basement membranes. The distribution of tenascin was also compared with that of actin-containing wound fibroblasts, myofibroblasts, which were detected using TRITC-phalloidin, as previously described (Doillon et al., 1987) .
Tenascin Is Associated with Basement Membranes in Normal Skin
In normal rat skin, tenascin was detected in a discontinuous distribution in the basement membrane of the dermal-epidermal junction, mostly close to hair follicles ( Fig. 1 B) . It was found in the basement membrane of subepidermal capillaries and hair follicles, but not of sebaceous glands, which are associated with hair follicles. There was strong tenascin staining in the sheaths of the large sensory tylotrich hair folli-
Figure 1. Distribution of tenascin in normal skin (A-D) and 24-h wounds (E-H).
Hyalumnidase-treated sections stained by indirect immunoperoxidase with preimmune serum (CS; A, E), anti-tenascin (Tn; B, F), and anti-fibronectin (Fn; C, G). In A-D, oblique sections of hair follicles (hf) are seen at two levels, close to the surface of the skin, and deeper, where they are associated with sebaceous glands (sg). (B) In normal skin, tenascin is present discontinuously in the dermal-epidermal junction beneath the epidermis (e), but staining is strong beneath the epidermal pad (ep); it is also present in the basement membranes of dermal capillaries (c) and hair follicles, but not sebaceous glands. (C) Fibronectin is present in basement membranes and diffusely throughout the dermis. (D) Staining with TRITCphalloidin (Ph) demonstrates that actin-containing fibroblasts are rare in the fibrous dermis, sm, smooth muscle. (F) 1 d after being wounded, tenascin staining is increased in the dermal-epidermal junction beneath the intact epidermis to the right of the cut edge of the wound (arrow). Tenascin staining can also now be seen diffusely in the dermis (d) adjacent to the wound. (G) Fibronectin staining is enhanced at all levels in the region of the wound. (H) Hematoxylin and eosin (HE) staining demonstrates the wound morphology. The dark band of cells to the left of the cut edge of the epithelium is an accumulation of polymorphonuclear leukocytes. Bar, 100 Ixm.
cles and of the epidermal pads, the area of thickened epidermis associated with tylotrich follicles (Straile, 1969) . Otherwise, staining in the fibrous connective tissue of the dennis was undetectable, as was staining of dermal smooth muscle. Tenascin staining of normal skin was considerably enhanced by hyaluronidase treatment of sections but unaffected by collagenase treatment. Like tenascin, fibronectin was present in capillary, hair follicle, and dermal-epidermal junction basement membranes, but was also weakly and diffusely distributed throughout the fibrous tissue of the dermis (Fig. 1  C) . TRITC-phalloidin showed faint, diffuse staining of the fibrous tissue of the normal dermis (Fig. 1 d) , as previously described (Doillon et al., 1987) . 
Tenascin Is Strongly Expressed in Healing Wounds by Light Microscopy
After surgical incision, a blood clot forms within the wound. Polymorphonuclear leukocytes accumulate at the edges of the wound. Within ~24 h, epidermis at the edges of the wound thickens and begins to migrate between the dermis and the eschar, which is the remains of the clot and wound exudate. Over the next few days, the wound space is filled with granulation tissue, consisting mainly of fibroblasts, macrophages, and endothelial cells forming new blood vessels. Collagen fibers are deposited and gradually organized parallel to the wound surface; then wound contraction takes place. Wound myofibroblasts are thought to be important in the contraction process (Majno et al., 1971; Rungger-Braendie and Gabbiani, 1983) . The time required for these events varies with the depth of the wound. 1 d after wounding, tenascin staining had become more intense at the dermal-epidermal junction and some staining was apparent in the dermis adjacent to the wound edge (Fig.  1 f ) . Fibronectin staining had become stronger in the dermis in the region surrounding the wound (Fig. 1 G) .
3 d after wounding, epidermal migration across superficial wounds was complete. Tenascin was abundant at the dermalepidermal junction underneath the newly migrated epithelium, and extending some distance from the wound edges towards the normal skin (Fig. 2 B) . At this stage, laminin staining was not yet continuous at the dermal-epidermal junction (Fig. 2 D) . In a 3-d medium-thickness wound, there was intense tenascin staining of the dermis at the wound edge, both in the region over which epidermis had already migrated, and beneath the eschar where epidermis had not yet migrated (Fig. 2 F) . Epidermis thus was migrating over a surface rich in tenascin. In both superficial and mediumthickness wounds, the distinction between the wound area and adjacent normal tissue was much more obvious with tenascin staining (Fig. 2, B and F) than with fibronectin staining (Fig. 2, C and G) . In a deeper 3-d wound in which the muscle layer was partially damaged, a sharp band of intense tenascin staining was visible all along the edge of the wound, in dermis, adipose tissue, and muscle layers (Fig. 2 H) .
Because tenascin is known to be produced by fibroblasts in culture and by various mesenchymal tissues (see Introduction) it seemed likely that the specialized wound fibroblasts, myofibroblasts, produce tenascin. Double staining of sections with anti-tenascin and TRITC-phalloidin demonstrated that tenascin's distribution was not well correlated with that of myofibroblasts (Fig. 2, E and F) . The area of dermis that was adjacent to the wound edge and contained myofibroblasts was more extensive than that containing tenascin.
In deep 6-d rat wounds, the wound space had been filled by a large amount of granulation tissue which had been partially covered by migrating epidermis. There was intense tenascin staining in the granulation tissue (Fig. 3 A) . Newly formed blood vessels in the granulation tissue could be seen by phalloidin staining of endothelium (Fig. 3 B) . Tenascin was not present in the basement membranes of these new vessels, which is demonstrated by comparison of tenascin and phalloidin staining of a single section at a high magnification (Fig. 3, A and B) . This section also demonstrates that, although bundles of actin in myofibroblast processes could easily be observed (Fig. 3 B) , very few tenascin-stained and in the injured dermis, c, capillary; d, dermis; e, epithelium; es, eschar; hf, hair follicle. (C) Fibronectin staining is enhanced in the wound area, but is also present in the noninjured dermis. (D) Laminin staining beneath the newly migrated epidermis is not yet continuous. In a section of a medium-thickness wound, double-stained with TRITC-phalloidin (E) and anti-tenascin (F), the area of actin-containing myofibroblasts in the dermis is more widespread than the area of tenascin staining. (Fig. 3 A) . Tenascin thus was predominantly distributed homogeneously throughout the extracellular spaces of the granulation tissue at this stage.
With time, granulation tissue contracts, bringing the former wound edges back together. The abundant granulation tissue is replaced by a narrow scar of collagen fibers aligned parallel to the surface of the wound. Soon after contraction had taken place, in a medium-thickness wound at 10 d, tenascin was only just detectable deep in the scar, but still abundant high in the scar close to the dermal-epidermal junction (Fig. 4 A) . In contrast, fibronectin was still evenly distributed in the scar (Fig. 4 B) . Tenascin was not present in the basement membrane of blood vessels in the scar soon after contraction (Fig. 4 A) , but had reappeared in the capillaries close to the epidermis some time later, when tenascin was totally undetectable in the fibrous tissue of the scar (Fig.  4 C) .
Ultrastructure of the Dermal-Epidermal Junction in Normal and Wounded Skin
To understand in more detail the architecture of the dermal-epidermal junction, wound tissue with the adjacent unwounded skin was investigated by EM. Attention was paid to the reestablishment of the basal lamina between epidermis and dermis (Fig. 5) . In normal skin, a 70-nm-thick basal lamina separated the epidermis from the dermis. The epidermal cells adhered to the basal lamina by numerous hemidesmosomes. The dermal stroma was invested with a dense network of 55-nm-thick collagen fibers (Fig. 5 B) . From the margin to the center of the wound, the basal lamina became thinner (40 nm) and progressively more discontinuous (Fig. 
5, C-E).
The basal lamina fragments were always apposed to the epidermal hemidesmosomes (see Fig. 5 D) . In the center of the wound, a basal lamina was not detectable and pioneer epidermal cells were sitting on an amorphous mass of extracellular matrix (Fig. 5 F) , or were in contact with macrophages (Fig. 5 G) . At the margin of the granulation tissue, the dermal stroma contained a network of 30-nmthick collagen fibers (Fig. 5, C-E) , whereas in the center of the wound amorphous matrix material was abundant (Fig. 5 , E and F).
Ultrastructural Detection of Tenascin in Normal and Wound 1Issue
In normal skin, tenascin was detected in the basal lamina of the dermal capillaries (Fig. 6 A) as well as in the basal lamina of the hair follicles (Fig. 7 B) . The collagen fibers that were apposed to these basal laminae were also decorated with tenascin. Collagen fibers >2 ~tm away from the basal lamina were tenascin negative (Figs. 6 A and 7 B) . The identity of the collagen fibers was established by counterstaining of the sections with uranyl acetate and lead citrate (Fig. 6 B) .
In the wound tissue, the distribution of tenascin changed from the margin to the center of the wound. At the periphery, where epidermis was intact but thickened, tenascin antibodies stained both the basal lamina (predominantly apposing the hemidesmosomes) and the surface of the collagen fibers in the adjacent dermal stroma (Fig. 7, C and D) . At the former wound edge, where the earliest epidermal migration had occurred, tenascin was found in the basal lamina fragments that separated the epidermal from the dermal cells (Fig. 7 E) . Staining of thick collagen fibers was no longer detectable and the tenascin in the stroma adjacent to the dermal-epidermal junction decorated an amorphous mass of extraceUular matrix. In the central areas of the wound, tenascin was only detectable in the amorphous matrix of the granulation tissue (Fig. 7 F) .
Migrating Epidermis Induces the Production of Tenascin by the Dermis
To determine whether any of the multitude of cytokines produced by the invading cells attracted to the site of injury were necessary for the production of tenascin by the dermis, skin explants were studied. It has previously been demonstrated that when skin explants are cultured floating on the surface of the medium, epidermis migrates over the cut edge of the dermis (Hashimoto et al., 1984) . Epidermal cell migration even occurs, albeit more slowly, in serum-free medium.
When such skin explants were cultured and then sectioned and examined by histochemistry, it was found that tenascin staining was strong in the dermal-epidermal junction and adjacent dermis under migrating epithelium (Fig. 8 B) . Epidermis from explants cultured in serum-free medium did not migrate as far, but tenascin was expressed under the epidermis that had migrated (not shown). Staining with antifibronectin (Fig. 7 C) and TRITC-phalloidin (Fig. 7 D) was weak and evenly spread throughout the sections, as in normal skin.
Discussion
Tenascin in normal skin was found to be only associated with basement membranes and hair follicle dermal sheaths. It was weakly and discontinuously detected at the dermal-epidermal junction. Tenascin was, however, strongly expressed in healing wounds. This dramatic change in expression suggests that tenascin is important in the wound healing process.
The association of tenascin with basement membranes, demonstrated in this study, is intriguing. Tenascin was detected in the basement membranes of subepidermal capillaries in normal skin, but not in capillaries of granulation tissue or the newly contracted scar. Tenascin was sparsely distributed in the basement membrane of normal epidermis, but abundant in the immature basement membrane of wound epidermis. In one situation tenascin thus indicates a mature basement membrane, and in another, an immature basement membrane.
Staining for tenascin was very intense at the dermal-epidermal junction beneath recently migrated epidermis and beneath the thickened, proliferating epidermis at the edges of the wound, extending towards the normal skin. In vitro, tenascin was again expressed at the dermal-epidermal junc- tion and in the dermis immediately underlying migrating epithelium. Such tenascin staining was not seen at the cut edge of the dermis, where epithelium had not yet migrated; it thus can be concluded that migrating, proliferating epithelium induces the expression of tenascin by dermal cells. This induction does not require the presence of serum or of the cell types, absent from normal skin, that appear in healing wounds.
Tenascin expressed at the dermal-epidermal junction may play a role in epidermal cell migration. Not only was tenascin found to be expressed in response to migrating epidermis, but it was also strongly expressed in the wound surface encountered by the front of migrating epidermis. The ability to migrate is an intrinsic property of epidermal cells, and can be markedly enhanced by epidermal growth factor and transforming growth factor-~t (Barrandon and Green, 1987) ; tenascin thus is obviously not required for migration. It seems likely, however, that a tenascin-containing substratum could provide ideal conditions for optimal movement of an epidermal cell sheet across the surface of a wound. The distribution of tenascin is well correlated with the pathways of neural crest cell migration and it has been speculated that tenascin promotes the migration of neural crest ceils by preventing them from attaching too well to fibronectin . A similar mechanism could also be involved in epidermal cell migration. On the other hand, the finding that tenascin is localized in basement membrane fragments opposite hemidesmosomes suggests that tenascin may be involved in adhesion of migrating epidermis.
Tenascin was strongly expressed at wound edges in the dermis and in the granulation tissue that filled deep wounds. In these areas, the distribution of tenascin was not well correlated with that of myofibroblasts. The electron microscopic study demonstrates that, in the dermis, tenascin associates either directly or indirectly with native collagen fibers. The coating of collagen fibers with tenascin may alter the interaction of cells or other extracellular matrix components with collagen. In the young granulation tissue at the center of the wound, in which no collagen fibers were seen, tenascin was present in amorphous deposits. Perhaps tenascin is only ever present in a fibrillar distribution when it can associate with collagen fibers.
The presence of tenascin in granulation tissue suggests that it may play a role in the development of this transient tissue. Fibronectin and collagen are known to promote fibroblast migration (Knox et al., 1986; Postlethwaite et al., 1978) . It is possible that tenascin, yet another extracellular matrix component, promotes migration into the wound area. The role of tenascin is, however, probably quite different from that of fibronectin, as their patterns of expression are so different. For example, tenascin may influence wound contraction. The contractile properties of myofibroblasts are widely thought to be responsible for wound contraction (reviewed by Rungger-Braendle and Gabbiani, 1983) . It has been suggested, however, that because myofibroblasts remain in the scar for some time after contraction, it is unlikely that these cells alone account for wound contraction (Doillon et al., 1987) . In this study, it was observed that granulation tissue ,x,5 mm across contracted to a scar ~50 ~tm wide. Whether or not myofibroblasts contract during wound contraction, they must also move considerably in relation to other ceils and the extracellular matrix surrounding them for this 100-fold reduction in wound width to be able to occur. Indeed, Baur and Parks (1983) have proposed a model of wound contraction in which myofibroblasts use their contractile ability to migrate through the extracellular matrix. These authors have described the myofibroblast anchoring strand, a direct connection between actin bundles within the myofibroblast and collagen fibers without. This connection would allow the translation of migratory movement into tissue deformation or wound contraction. Tenascin, which inhibits the attachment of mesenchymal cells to fibronectin in vitro (Mackie et al., 1987b) , could limit the myofibroblast's ability to adhere to the extracellular matrix surrounding it, thus allowing it to continue moving. Indeed, tenascin disappeared more rapidly than fibronectin or actin-containing myofibroblasts after wound contraction was complete. After contraction, unimpeded adherence of cells to the surrounding matrix through fibronectin would once more be desirable, to stabilize the scar.
The results of this study suggest that tenascin has an important and unique role in the wound healing process and demonstrate that its expression is subject to regulatory mechanisms quite different from those for fibronectin.
